1 / 95

Toxic Metals, Cardiovascular Disease, and EDTA Chelation Therapy

Toxic Metals, Cardiovascular Disease, and EDTA Chelation Therapy. Jeffrey A. Morrison, M.D., C.N.S. 461 Park Avenue South, 12 th Floor New York, NY 10016 www.morrisonhealth.com. Financial Conflict Statement.

sibley
Download Presentation

Toxic Metals, Cardiovascular Disease, and EDTA Chelation Therapy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Toxic Metals,Cardiovascular Disease,and EDTA Chelation Therapy Jeffrey A. Morrison, M.D., C.N.S. 461 Park Avenue South, 12th Floor New York, NY 10016 www.morrisonhealth.com

  2. Financial Conflict Statement I have no relevant financial relationships with any commercial interests to disclose.   The content of this presentation has been peer reviewed for fair balance and evidence based medicine.

  3. Learning Objectives: Relevance of TACT trial Connection between toxic metals, CVD and EDTA Tests for Toxic metals Treatment strategies for Toxic metals and CVD EDTA chelation protocol Case studies

  4. TACT Trial

  5. TACT Trial (Trial to Assess Chelation Therapy) Purpose – To determine the safety and effectiveness of EDTA chelation therapy in individuals with CAD Study Design – Double Blind, Placebo Control Sponsor – NIH and NCCAM Study lead investigator – Tony Lamas, M.D. Enrollment – 1708 patients Total infusions – 55,222 Start date – September 2003 End date – October 2012

  6. TACT Trial – Trial to Assess Chelation Therapy

  7. TACT Trial – Trial to Assess Chelation Therapy Outcome:

  8. What’s the connection? • CVD • Heavy metals • EDTA chelation

  9. Heavy (Toxic) Metals • Heavy metals are generally considered to be those that negatively impact patients health.

  10. Lead Lead education focused on Kids

  11. Lead – Toxicity in Children

  12. Lead – Our focus

  13. Lead pipe in domestic water systems until 1970 Glazed jugs – red / yellow lead crystal – 12-28% Embedded bullet Sniffing petrol fumes Herbal medicine Paints, varnish, polishes Dirt in your garden Paint chips Industrial exposure: metal smelter car/ship wrecking Construction petroleum refining Lead – acid battery paint manufacturing Lead – Typical Sources of Exposure

  14. Lead – Unlikely sources of Exposure

  15. Lead – In Jewelry

  16. Lead – In Lipstick

  17. Lead – In Purses

  18. Lead – In Vinyl Blinds and Candles

  19. Lead – In Water Acidic chemicals added to water magnify the uptake of lead into the body 98% of homes have lead in their plumbing from lead and copper pipes connected by lead solder Chrome-plated faucets are made of brass containing up to 8% lead

  20. Lead – Adverse Health Affects • Symptoms of Lead Poisoning/ Accumulation • Fatigue / irritability • Hearing loss • Reduced IQ • Infertility • Hypertension • Heart disease • Chronic Kidney Disease • Peripheral Neuropathy • Arthralgia, Myalgias and Gout • Nausea / constipation • Antisocial (criminal) behavior • Seizures, coma, death, at very high levels

  21. Lead – Blood Levels Considered Elevated

  22. Lead – Adverse health effects HTN Associated with MI and Stroke Chronic Kidney Disease (CKD) What’s the evidence?

  23. Lead – Associated with HTN in Men

  24. Lead – Associated with HTN in Women

  25. Lead – Associated with MI and Stroke

  26. Lead – Bone stores associated with IHD

  27. Lead – Associated with CV Mortality

  28. Lead – Causes Cardiovascular Disease

  29. Lead – Causes Chronic Kidney Disease (CKD)

  30. Lead – Accelerates Renal Disease

  31. Lead – How does it cause CVD?

  32. NO – Nitric Oxide and CVD

  33. NO – Nitric Oxide and CVD • Signaling molecule • Powerful vasodilator • Vascular endothelium involved in release of NO • aka – endothelium-derived relaxing factor (EDRF) • Drugs that enhance NO production: • NTG • Viagra • “Endothelial dysfunction is the initial step in pathogenesis of atherosclerosis”

  34. NO – Nitric Oxide and CVD

  35. Lead - adverse health affects • Mechanism of disease progression • Causes - oxidative stress • Produces - reactive oxygen species (ROS) • Lowers - production of NO • Leads to development of diseases: • HTN • CAD • IDCM • MI and Stroke • Chronic Kidney Disease (CKD)

  36. Tests for Toxic Metals Blood – gold standard for acute exposure Urine – accepted for assessing body burden Hair – rarely recommend

  37. Heavy Metal Testing – Blood Lead

  38. Heavy Metal Testing - Urine

  39. Heavy Metal Testing – Urine is Reliable

  40. Heavy Metal Testing - Hair

  41. Treatment Strategies Avoid Exposure Sweating Chelation therapy

  42. Treatment Strategies – Avoid Exposure • Lead • Remove lead paint from your home • Use lead test strips • Drink filtered water • Choose herbal products tested for heavy metals

  43. Treatment Strategies – Avoid Exposure

  44. Treatment Strategies – Sweating Sauna and Exercise remove heavy metals

  45. Treatment Strategies – Sweating

  46. Treatment Strategies – Sweating safe for CAD

  47. Treatment Strategy – Chelation therapy Removal of toxic metals May improve CVD and renal insufficiency

  48. Table of chelating agents

  49. Definition of Chelation Therapy The word chelate is derived from the Greek word chele (claw of a crab) implying the firm binding action of a chemical to a metal ion. Morgan and Drew defined the term chelation in 1920 as - the incorporation of a metal ion into a Heterocyclic Ring Structure

  50. Heterocyclic Ring Structure in Nature Chlorophyll is a chelate of Magnesium

More Related